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Objective. Cervical human papillomavirus (HPV) infection has been associated with human immunodeﬁciency virus (HIV)
acquisition in populations with a high prevalence of both infections. Procedures performed in the management of cervical
dysplasia may facilitate HIV entry via mechanical injury. We sought to investigate the association between cervical procedures and
incidentHIV.Methods.Dataoncervicalcancerscreeningandprocedureswerecollectedinacohortstudyevaluatingthediaphragm
for HIV prevention in 2040 women. In this secondary analysis, we investigated the association between cervical procedures and
HIV acquisition. Results. Out of 2027 HIV-negative women at baseline, 199 underwent cervical procedures. Cumulative risk of
HIV was 4.3% over 21 months of median followup (n = 88). Compared with women without cervical procedures, we observed
no diﬀerence in HIV incidence after a cervical biopsy (RR 0.92, 95% CI 0.39–2.16), endocervical curettage (RR 0.29, 95% CI 0.07–
1.22), or loop electrosurgical excision procedure (RR 1.00, 95% CI 0.30–3.30). Conclusions.I nt h i sc o h o r t ,c e r v i c a lp r o c e d u r e s
were not associated with HIV incidence. This lack of association could be due to the small number of events.
1.Introduction
Human papillomavirus (HPV) infection is one of the most
common sexually transmitted infections worldwide. More
than thirty subtypes of HPV can infect the anogenital tract,
and speciﬁc high-risk types can lead to dysplasia and cancers
of the anogenital tract in both men and women [1, 2]. It is
well established that HIV-infected men and women are at
increasedriskofanogenitalHPVinfection;yet,untilrecently,
little was known about the potential role of HPV infection in
HIV acquisition. Recent studies suggest that infection with
various HPV subtypes, both oncogenic and nononcogenic,
is ass-ociated with increased risk of HIV acquisition in men
and women [3–8].
One explanation for the association is that cervical
procedures performed as part of the evaluation and treat-
ment of HPV-induced cervical dysplasia provide a portal
of HIV entry due to disruption of the normal mucosal2 ISRN Obstetrics and Gynecology
barrier. Currently, there is little information about whether
procedures performed as part of cervical cancer screening
programs confer an increased risk of acquisition. In this
study, we investigated whether cervical procedures per-
formed in the evaluation of abnormal cervical cytology were
associatedwithanincreasedriskofHIVacquisitioninalarge
cohort of women in Zimbabwe.
2.MaterialsandMethods
2.1.StudyDesignandParticipants. Participantsweresexually
active HIV-negative women enrolled in a randomized trial
assessing the eﬀect on HIV seroincidence of providing a latex
diaphragm with a lubricant gel along with male condoms
compared with male condom provision alone [9]. Results
from the overall trial demonstrated that diaphragm/gel
provision added no signiﬁcant protection against acquisition
of HIV [9] or sexually transmitted infections [10]; hence,
data from the intervention and control arms were pooled for
this study. For the parent study, women were recruited from
September 2003 to September 2005; beginning in February
2004, enrollment in a study evaluating HPV outcomes [11]
was oﬀered to main trial enrollees at the Zimbabwe sites;
2040 of 2089 (97.6%) women accepted and gave written
informed consent. For the present study, we performed a
secondary analysis of data collected from the HPV study at
the Zimbabwe sites.
2.2.StudyProcedures. Proceduresforthisstudyaredescribed
in detail elsewhere [9]. At baseline, information on demo-
graphics and sexual behavior was collected, all participants
were tested for HIV and HSV-2 using antibody testing,
samples were collected for Neisseria gonorrhea, Chlamydia
trachomatis,andTrichomonasvaginalis,andcervicalcytology
and an HPV swab were collected in all patients. Follow-
up visits occurred every 3 months between enrollment
(earliest in February 2004) and September 2006. Questions
on demographics and sexual behavior were asked again, and
samples were collected for HIV, HSV-2, Neisseria gonorrhea,
Chlamydia trachomatis, Trichomonas vaginalis,a n dH P V .
Women were treated for these coinfections if found to be
positive. Methods for HPV sample collection and testing
have been previously described [7]. Cervical cytology was
interpretedinZimbabwebyasinglepathologistandreported
using the Bethesda system [12].
2.3. Management of Cervical Cytology Results. The schema
for management of abnormal cytology is shown in Figure 1.
Women with a result of high-grade squamous intraepithe-
lial lesion (HSIL), adenocarcinoma in situ (AIS), atypi-
cal glandular cells (AGC), or cancer at enrollment were
referred for colposcopy. Women with low-grade squamous
intraepithelial lesion (LSIL) or atypical squamous cells of
undetermined signiﬁcance (ASC-US) had repeated cytology
in 6 months and were referred for colposcopy if that test
was abnormal. All participants received a cervical cytology
test at study exit and were referred for colposcopy if that
test was abnormal. Loop electrosurgical excision procedure
(LEEP) was performed if the colposcopically directed biopsy
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atypia/cancer
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Repeat cytology in 6
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Figure 1: Algorithm for management of cervical cytology results.
diagnosis was cervical intraepithelial neoplasia 2 or 3 (CIN2
or CIN3) or adenocarcinoma in situ (AIS).
2.4. HIV Testing. Two rapid HIV tests were performed at
screening and at quarterly follow-up visits using meth-
ods described elsewhere [7]. Discordant results on rapid
antibody tests were conﬁrmed by ELISA. Once a serologic
diagnosis of HIV was made, timing of HIV acquisition was
assessedbyRNAorDNAPCRondriedbloodspotsfromthat
visit and prior visits until a negative PCR test was obtained.
Date of HIV acquisition was the visit at which the ﬁrst PCR
test was positive.
2.5. Statistical Methods. We designed an ap r i o r ianalytic
plan to investigate associations between HIV incidence and
cervical procedures (cervical biopsy, endocervical curettage
(ECC), and LEEP). We excluded from the analysis those
participants whose HIV diagnosis preceded any cervical
procedure, those without an HIV test following their cervical
procedures, and those with HIV tests performed less than 2
weeks after a cervical procedure (a time frame during which
a test for HIV might provide a false-negative test result).
In univariate analyses, we ﬁrst evaluated the association
between speciﬁc cervical procedures (cervical biopsy, ECC,
andLEEP)andHIVacquisition.Wethencreatedacomposite
variable (cervical biopsy, ECC, or LEEP) and evaluated its
association with HIV acquisition. In multivariate analyses,
we adjusted for 3 baseline variables that had previously been
shown to be signiﬁcant predictors of HIV acquisition: high-
risk partner, positive HSV serology, and condom use (some-
times/always versus never) [7]. In a separate exploratoryISRN Obstetrics and Gynecology 3
Table 1: Baseline sociodemographic characteristics, reproductive history, sexual behaviors, and clinical characteristics (N = 2040).
Characteristic Number Percentage
Age
24 years or younger 758 37.2%
25 to 34 years 937 45.9%
35 years or older 345 16.9%
Tested positive for herpes simplex virus-2 serology 1034 50.8%
High-risk partner: at least one indicator1 1343 65.9%
Frequency of condom use in the past 3 months
Never 615 30.1%
Sometimes 876 43%
Always 548 26.9%
Normal cervical cytology at baseline 1674 82.3%
1Indicators include having any sexual partners test positive for HIV, suspect or knowing that regular partner had other sex partners in the last 3 months, ever
had vaginal sex when partner was under inﬂuence of drugs/alcohol in the last 3 months, or regular partner was away from home for 1 or more months.
analysis, we evaluated the association between timing of
cervical procedures and HIV acquisition. We postulated that
within a 3-month period following any cervical procedure,
women were at increased risk of HIV due to mechanical
damage to the cervix compared to women who had had
cervical procedures >3 months ago and those who had
never had a cervical procedure (reference group). The model
was controlled for baseline variables deﬁned a priori as
above, speciﬁcally partner risk, HSV status, and condom use.
We used the Cox proportional hazards model to analyze
the association between timing of cervical procedures and
HIV acquisition (STATA 10 for Windows).
3. Results
3.1. Characteristics of the Study Population. Of the 2089
women approached, 2040 women (97.6%) consented to
participate in the study. We excluded 13 women from this
analysis: 9 women who were HIV positive at baseline and
4 with an HIV diagnosis preceding cervical procedures
(Figure 2). Therefore, this analysis was based on a total of
2027 participants, of whom 1932 (94.7%) had complete
follow-up data. The median follow-up time was 21 months
(range 12–24 months), and the cumulative HIV incidence
was 4.3% (n = 88).
A detailed summary of the participants’ baseline demo-
graphic and biological characteristics has been previously
reported [7–10].Table 1 presentsabriefsummary.Themean
age of study participants at enrollment was 27 years (range
18–49years).Mostofthewomenreportedlivingwitharegu-
larpartner.Themeannumberoflifetimesexualpartnerswas
low at 1.3 (range 1–20). Approximately 7% of participants
had gonorrhea, Chlamydia, Trichomonas vaginalis, or syphilis
at baseline. All identiﬁed coinfections were treated, and
screening was repeated at 3-month intervals. Approximately
50% of women had serologic evidence of prior exposure to
HSV-2. Prevalence of HPV infection at baseline was 24.5%.
A total of 1674 women had normal cervical cytology
at baseline (82.2%). The remainder had ASC-US (n = 72,
3.5%), LSIL (n = 102, 5%), HSIL (n = 12, 0.6%), AGC
(n = 13, 0.6%), or other cytologic abnormalities (n = 75,
Enrolled in HPV study at
N = 2040
No procedures
(control group)
N = 1828
Included in
secondary analysis
N = 2027
Underwent any
cervical procedure
N = 199
Excluded because HIV
diagnosis at baseline
N = 9
Excluded because HIV
diagnosis before
cervical procedures
N = 4
Zimbabwes site
Figure 2: Trial proﬁle: HPV study.
3.7%). There were 89 unsatisfactory cytologic tests (4.4%),
and 3 missing results (0.15%).
There were 199 women who underwent one or more
cervical procedures (Figure 2), of whom 138 had at least one
cervical biopsy, 141 had an ECC, and 64 underwent LEEP. Of
the participants included in our analysis who acquired HIV,
7 had undergone one or more cervical procedures.
3.2. Association of Cervical Procedures with Risk of HIV
Acquisition. Our priori logistic regression model examined
the association between cervical biopsy, ECC, and/or LEEP
on risk of HIV acquisition; the results are summarized
in Table 2. We found no statistically signiﬁcant association
betweencervicalproceduresandHIVacquisition.Theresults
were similar when adjusted for baseline variables associated
with HIV acquisition (positive HSV serology, having a high-
risk partner, and always or sometimes using condoms).
In a separate analysis, we examined whether cervical
procedures performed within 3 months increased the risk of4 ISRN Obstetrics and Gynecology
Table 2: Eﬀect of cervical procedures at any time on risk of HIV acquisition.
Variable HIV acquisition n/N
(%)
Unadjusted relative risk
(95% CI) P value Adjusted∗ relative risk
(95% CI) P value
Cervical biopsy
No biopsy
6/142 (4.2)
78/1885 (4.1) 1.02 (0.43–2.38) 0.96 0.92 (0.39–2.16) 0.85
ECC
No ECC
2/137 (1.4)
82/1890 (4.3) 0.32 (0.07–1.34) 0.12 0.29 (0.07–1.22) 0.09
LEEP
No LEEP
3/64 (4.7)
81/1963 (4.1) 1.14 (0.35–3.71) 0.83 1.00 (0.30–3.30) 0.99
Any procedure
No procedure
7/199 (3.5)
77/1828 (4.2) 0.82 (0.37–1.82) 0.64 0.74 (0.33–1.65) 0.47
CI indicates conﬁdence interval, ECC: endocervical curettage, LEEP: loop electrosurgical excision procedure.
∗Adjusted for the following baseline variables: positive serology for HSV-2, high-risk partner as deﬁned in Table 1’s footnote, sometimes or always using
condoms (compared to no condom use) within the last 3 months.
Table 3: Eﬀect of any cervical procedure within the last 3 months
on risk of HIV acquisition§.
Variable
Unadjusted
hazard ratio
(95% CI)
P value
Adjusted∗
hazard ratio
(95% CI)
P value
Procedure
within 3
months
2.64
(0.64–10.8) 0.177 2.27
(0.55–9.36) 0.253
CI indicates conﬁdence interval.
§Comparison group: no procedure ever and procedure >3m o n t h sa g o .
∗Adjusted for the following baseline variables: positive serology for HSV-2,
high-riskpartnerasdeﬁnedinTable 1’sfootnote,sometimesoralwaysusing
condoms (compared to no condom use) within the last 3 month.
HIV acquisition compared to no procedures or procedures
>3 months ago. This analysis used a Cox proportional haz-
ards model to investigate the association between procedure
withinthelast3monthsandHIVacquisition.Only2partici-
pants acquired HIV within 3 months of a cervical procedure.
We found that women with recent cervical procedures did
not have a statistically signiﬁcant increased likelihood of
HIV acquisition compared with women without cervical
procedures in this interval (Table 3).
4. Discussion
This pilot study provides a new insight into the risk of HIV
acquisition associated with mechanical injury to the cervix
due to procedures related to cervical cancer screening. Our
resultsshownorelationshipbetweencervicalproceduresand
risk of HIV acquisition; however, they need to be interpreted
cautiously for several reasons.
Of the 199 women who underwent cervical procedures,
only 7 women acquired HIV, and, among women who had
a recent cervical procedure (within the last 3 months), only
2 acquired HIV. This low number of outcomes can certainly
explain our negative ﬁndings.
Our study was hypothetically subject to confounding
given that all the women who underwent cervical procedures
were counseled to abstain from sex for 4 weeks following cer-
vical treatment; therefore, behavior modiﬁcation could have
resulted in decreased exposures to HIV during a potential
period of susceptibility. However, any diﬀerence in sexual
behavior between the two groups would have been limited
to the ﬁrst month following the cervical procedures.
There are limited data in the literature reporting
the eﬀect of cervical procedures on the risk of HIV acqui-
sition. The eﬀect of cervical procedures (cryosurgery, LEEP,
and cone) on genital tract shedding and HIV transmission
was investigated in a study by Wright et al. in 2001 [13].
This study showed greater than 10,000-fold increased local
viral replication and genital shedding which persists for
up to 4 weeks following treatment. This increased genital
shedding,thoughttobeduetocervicalinﬂammationleading
to local activation of CD4 lymphocytes, could translate
into a signiﬁcantly increased risk of HIV transmission for
partners of HIV-infected women. In HIV-negative women,
cervical inﬂammation due to cervical procedures could
theoreticallyincreasethenumberofHIVtargetcellsandlead
to increased susceptibility to HIV acquisition.
Table 1 shows a protective, though not statistically signif-
icant, eﬀect of endocervical curettage on HIV acquisition.
It was our hypothesis that any cervical procedure leading
to cervical inﬂammation may lead to increased risk of
HIV acquisition. Therefore, it is unclear how to explain
the protective trend shown between endocervical curettage
and HIV acquisition, although the small numbers of out-
comes of HIV acquisition must be considered.
There are several strengths to our analysis, including a
large sample size, a low rate of loss to followup, and frequent
followup. Limitations include a small number of HIV
acquisition events, which aﬀected the power and statistical
precision of our ﬁndings. There were seven outcomes (HIV
acquisition) in total among the 199 women who underwent
procedures in this exploratory analysis. Larger studies need
to be performed to conﬁrm our ﬁndings such that we can
be assured that procedures associated with cervical cancer
screening and management are safe for women in areas with
high endemic HIV rates.
5. Conclusions
This pilot study suggests that cervical procedures are not
associated with an increased risk of HIV acquisition: results
are not meant to be deﬁnitive given the low number of
outcomes. We hope this investigation prompts larger studiesISRN Obstetrics and Gynecology 5
on the association between cervical procedures and HIV
acquisition in women, especially in areas of high HIV
prevalence.
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